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ABSTRACT 
Prion diseases are transmissible neurodegenerative disorders that are invariably fatal 
in human and animals. Although the nature of the infectious agent and pathogenic 
mechanisms of prion diseases are not clear, it has been reported to be associated with 
aberrant metabolism of cellular prion protein (PrPc). In various reports, it has been 
postulated that PrPc may be involved in programmed cell death or apoptosis. 
Apoptosis of neuronal cells can also be induced in vitro by exposure to PrPsc or a 
neurotoxic peptide fragment corresponding to amino acids 106-126，118-135 of 
human prion protein (PrP106-126；PrP118-135). While the anti-apoptotic and 
anti-oxidative function of PrPc is regulated by not only OR (Octapeptide 
Region,amino acid residue 51-91) but also the N-terminal half of HR(Hydrophobic 
Region, amino acids residue 95-132). PrPc may participate in apoptosis through 
extrinsic pathway by binding to certain chaperon molecules or through induced by 
certain stresses like inflammatory factors. It can also by modulating Bcl-2/Bax, 
endogenous dismutase activity and calcium channel, control the activation and 
translocation of the mitochondria which leads to apoptosis involving certain effective 
molecules of caspase family. Meanwhile above biological events would be controlled 
by cAMP/APK, p38/MAPK, JNK, p53, NF-κB pathways et al. Further understanding 
of the apoptosis in PrPc have important implications for designing therapy of prion 
diseases, as well as for understanding pathogenic mechanisms operative in other 
neurodegenerative disorders and the role of prion in biology. 
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INTRODUCTION 
Apoptosis, or programmed cell death, is a 
major control mechanism by which cells 
die if DNA damage is not repaired (Lowe 
S and Wand Lin AW, 2000). Apoptosis 
is also important in controlling cell 
number and proliferation as part of 
normal development. 
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Prion diseases are transmissible 
neurodegenerative disorders that are 
invariably fatal in humans and animals. 
Although the nature of the infectious 
agent and pathogenic mechanisms of 
prion diseases are not clear, it has been 
reported that prion diseases may be 
associated with aberrant metabolism of 
cellular prion protein 
(PrPc)( Mastrangelo P and Westaway 
D,2001). In various reports, it has been 
postulated that PrPc may be involved in 
one or more of the following: 
neurotransmitter metabolism, cell 
adhesion, signal transduction, copper 
metabolism, antioxidant activity or 
programmed cell death(Kim BH et al., 
2004). 
 
Various evidences proved the 
involvement of apoptosis in the 
biological metabolism of PrPc. The 
analysis of chromatin structure in cases 
of human spongiform encephalopathies 
could show the possible involvement of 
apoptosis in neuronal cell death. 
Genomic DNA was purified from 
peripheral blood lymphocytes and from a 
biopsy of the brain cortex in a case of 
Creutzfeldt-Jakob disease. The DNA 
purified from the brain consisted of 
partially degraded DNA in 
internucleosomal-sized fragments, 
whereas the DNA from peripheral blood 
lymphocytes showed unbroken DNA of 
high molecular weight. These results are 
consistent with the possible activation of 
the apoptotic endonuclease and the 
internucleosomal fragmentation of DNA 
of the brain cortex in the patient affected 
by Creutzfeldt-Jakob disease, suggesting 
the involvement of apoptosis in neuronal 
cell death in human spongiform 
encephalopathy (Lucas M et al., 1997). 
Histological and electron microscopical 
studies have shown that cell death in 
prion disease occurs in form of apoptosis. 
Kim BH et al (Kim BH et al., 
2004)established the cell lines stably 
expressing PrPc from PrP knockout 
(PrP(-/-)) neuronal cells and examined 
the role of PrPc under apoptosis and/or 
serum-deprived condition and found that 
PrP(-/-) cells were vulnerable to 
apoptotic cell death and that this 
vulnerability was rescued by the 
expression of PrPc. Apoptosis of 
neuronal cells can also be induced in 
vitro by exposure to PrPSc or a 
neurotoxic peptide fragment 
corresponding to amino acids 106-126，
118-135 of human prion protein 
(PrP106-126；PrP118-135). Both in vitro 
and in vivo the toxicity of PrPsc and PrP 
fragments appears to depend on neuronal 
expression of PrPc and on microglial 
activation. Activated microglial cells 
release pro-inflammatory cytokines and 
reactive oxygen species. Cell culture 
experiments suggest an important role of 
microglia-mediated oxidative stress in 
the induction of neuronal cell death 
(Giese A and Kretzschmar HA, 2001). 
It’s reported recently that only 
prion-infected neuronal cells become 
apoptotic after mild inhibition of the 
proteasome, and this was strictly 
dependent upon sustained propagation of 
PrPsc. Whereas cells overexpressing 
PrPc developed cytosolic PrPc 
aggregates, this did not cause cell death. 
In contrast, only in prion-infected cells, 
mild proteasome impairment resulted in 
the formation of large cytosolic 
perinuclear aggresomes that contained 
PrPsc, heat shock chaperone 70, 
ubiquitin, proteasome subunits, and 
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vimentin. Similar structures were found 
in the brains of prion-infected mice. 
PrPsc aggresome formation was directly 
associated with activation of caspase 3 
and 8, resulting in apoptosis(Kristiansen 
M et al.,2005). Abundant experiments in 
our lab also revealed that the vitro 
transfectant of AGS/PrPc was more 
resistant to serum deprivation induced 
apoptosis compared to that of control cell 
line AGS/pcDNA3.1B, suggesting PrPc 
expression, which was universal in 
gastric cell lines and presented high level 
in gastric carcinoma, was at least partly 
mediated though certain anti-apoptotic 
mechanism(Du J et al., 2005; Liang J et 
al., 2006). As for the structure of PrPc 
related to apoptosis, involved pathways 
and regulation of the apoptotic proteins 
were concluded below. 
 
Structure of PrPc related to apoptosis 
Cellular prion protein (PrPc), synthesized 
in endocytoplasmic reticulum and 
anchored on the extracellular face of the 
plasma membrane by a 
glycosylphosphatidyl-inositol moiety, its 
structure has not been determined 
directly for practical reasons. The human 
PrPc molecule contains a signal peptide 
(1–22), five octapeptide repeats (51–91), 
a highly conserved hydrophobic region 
(112–145), three peptide sequences 
responsible for -helix structure (H1, H2 
and H3), and a signal sequence for GPI 
anchor (231–254)(Fig 1). PrP primary 
and tertiary structures are highly 
conserved in mammals, which suggest 
that this protein participates in 
fundamental biological processes, 
however, the role of PrP in the cell 
remains uncertain. Previous studies have 
showed the amino acids 106-126 ，
118-135 of human prion protein 
(PrP106-126；PrP118-135), as well as the 
OR(Octapeptide Region,amino acid 
residue 51-91) , N-terminal half of 
HR(Hydrophobic Region, amino acids 
residue 95-132) involved in the apoptosis 
function. 
 
igure 1: Representation of the domains of PrPc. The human PrPc molecule 
rP 106-126 
peptide homologous to 
maintains many characteristics of PrPsc, 
F
contains a signal peptide (1–22), five octapeptide repeats (51–91), a highly conserved 
hydrophobic region (112–145), three peptide sequences responsible for -helix 
structure (H1, H2 and H3), and a signal sequence for GPI anchor (231–254). 
Numbers below the boxes correspond to the amino acids in each domain. Double 
arrows indicate the domains of PrPc related to apoptosis, which is also represented 
by amino acid numbers in parentheses.  
 
P
A synthetic 
residues 106-126 of PrP (PrP 106-126) 
that is, the ability to form amyloid fibrils 
and to induce apoptosis in neurons. In 
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vitro or vivo variant experiments have 
been carried out to examine the 
PrP106-126 induced apoptosis. Forloni G 
et al(Forloni G et al., 1993) first reported 
neuronal death resulting from chronic 
exposure of primary rat hippocampal 
cultures to micromolar concentrations of 
a peptide corresponding to residues 
106-126 of the amino-acid sequence 
deduced from human PrP complementary 
DNA. DNA fragmentation of 
degenerating neurons indicated that cell 
death occurred by apoptosis. Then he 
used chronic (5-7 d) exposure to 
PrP106-126 fragment induced neuronal 
death by apoptosis model, as suggested 
by biochemical and morphological 
analysis, confirmed by ultrastructural 
examination the apoptotic 
mechanism(Forloni G et al., 1996). 
Kretzschmar HA et al(Kretzschmar HA 
et al., 1997) using the synthetic peptide 
of the prion protein (PrP106-126) 
showed that this peptide was toxic only 
to normal neurons whereas nerve cells 
derived from PrP knock-out (PrP0/0) 
mice were unaffected by this neurotoxic 
effect. Later the synthetic peptide PrP 
106-126, obtained from the 
amyloidogenic region of the PrP, 
constituted a classic model system to 
study prion-induced neurodegeneration 
as it retained the ability to trigger cell 
death in neuronal cultures(O'Donovan 
CN et al., 2001; Ciesielski-Treska J et al., 
2004; Bergstrom AL et al., 2005). 
 
PrP 118-135 
eptid
Prion protein fragment (118-135) 
membrane-destabilizing 
8-135 
es may trigger different pathways 
displays 
properties and is able to induce, in a 
nonfibrillar form, the fusion of 
unilamellar liposomes by which 
apoptosis could also be induced. Low 
concentrations of the PrP 118-135 
peptide, in a nonfibrillar form, induces a 
time- and dose- dependent apoptotic cell 
death on rat cortical neurons, including 
caspase activation, DNA condensation, 
and fragmentation (Pillot T et al., 2000). 
Knock-out PrP gene mice exhibites 
similar sensitivity to the nonfibrillar 
PrP118-135-induced cell death and 
electrical perturbations, strongly 
suggesting that cell death occurs 
independently of PrP expression. 
Interestingly, a variant nonfusogenic 
PrP118-135 peptide has no effects on in 
vivo neuronal viability, suggesting that 
the PrP118-135-induced cell death is 
mediated by its membrane destabilizing 
properties(Chabry J et al., 2003).  
 
However, PrP106-126 and PrP11
p
leading to neuronal apoptosis. Sponne I 
et al(Sponne I et al., 2004) used humanin 
(HN), which was shown to protect 
neuronal cells from various insults 
involved in human neurodegenerative 
diseases, to modulate the apoptosis 
induced by the soluble PrP118-135 and 
PrP106-126 fragment. The effects of HN 
did not require a preincubation with the 
PrP118-135 fragment, strongly 
suggesting that these peptides rescue 
cells independently of a direct interaction 
with the prion peptide. By contrast HN 
had no effect on the fibrillar PrP106-126 
peptide-induced cell death. This 
protective effect for neurons from 
PrP118-135-induced cell death strongly 
suggests that PrP118-135 and 
PrP106-126 peptides may trigger 
different pathways leading to neuronal 
apoptosis. However, the mechanism 
remains to be elucidated. 
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N-terminal octapeptide repeat region 
ellular prion protein PrPc contains two 
ng 
ys involved in PrPc and 
poptosis 
osis and apoptosis. Cells that 
r cytoplasmic pathway 
his pathway comprises several protein 
ptors, 
C
evolutionarily conserved domains amo
mammals: the octapeptide repeat region 
(OR; amino acid residue 51-90) which 
requires for selective binding to copper 
ions and the hydrophobic region (HR; 
amino acid residue 112-145). Both 
domains in N-terminal are vital to 
anti-apoptosis function. Some studies 
revealed that removal of the OR could 
enhance apoptosis and decrease SOD 
activity. Deletion of the N-terminal half 
of HR (amino acids residue 95-132) 
could abolish its ability to activate SOD 
and to prevent apoptosis, whereas that of 
the C-terminal half of HR (amino acids 
residue 124-146) has little if any effect 
on the anti-apoptotic activity and SOD 
activation(Sakudo A et al., 2005). These 
data are consistent with a model in which 
the anti-apoptotic and anti-oxidative 
function of PrPc was regulated by not 
only OR but also the N-terminal half of 
HR, suggesting copper binding and 
neuronal trafficking both contributes to 
PrPc functioning in vivo, hence provided 
clue to current hypotheses to explain 
Dpl/PrPc antagonism, by competitive 
ligand binding, plays a pro-apoptotic role 
(Drisaldi B et al., 2004; Sakudo A et al., 
2005). 
 
Pathwa
a
There are two major mechanisms of cell 
death-necr
are damaged by external injury undergo 
necrosis, while cells that are induced to 
commit programmed suicide because of 
internal or external stimuli undergo 
apoptosis. The first, referred to as the 
extrinsic or cytoplasmic pathway, is 
triggered through the Fas death receptor, 
a member of the tumor necrosis factor 
(TNF) receptor superfamily(Zapata JM et 
al., 2001). The second pathway is the 
intrinsic or mitochondrial pathway that 
when stimulated leads to the release of 
cytochrome-c from the mitochondria and 
activation of the death 
signal(Hockenbery D et al., 1990). Both 
pathways converge to a final common 
pathway involving the activation of a 
cascade of proteases called caspases that 
cleave regulatory and structural 
molecules, culminating in the death of 
the cell. The pathways are linked; 
overexpression of Bcl-2 in the intrinsic 
pathway may lead to the inhibition of 
extrinsic mediated apoptosis (Scaffidi C 
et al., 1998). Thus, any distinction 
between the two pathways would be 
simplistic. 
 
Extrinsic o
T
members including the death rece
the membrane-bound Fas ligand, the Fas 
complexes, the Fas-associated death 
domain, and caspases 8 and 10, which 
ultimately activate the rest of the 
downstream caspases leading to 
apoptosis. PrPc, the membrane protein, 
could bind to other proteins or suffer 
from stress like inflammatory 
factors(Veerhuis R et al., 2002) to block 
pro-apoptotic pathway. Binding proteins 
or chaperon molecules, first supposed by 
Pruisner as proteinX(Telling GC et al., 
1995), and later proved to be LR/LRP, 
ST1, HSP and so on, summed in the chart 
by Kil Sun Lee et al (Kil Sun Lee et al., 
2003), could induce signals to rescue 
cells from apoptosis . For example, 
amino acids 113-128 from PrPc and 
230-245 from STI1 cell surface binding 
and pull-down experiments showed that 
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recombinant PrPc binds to cellular STI1, 
and co-immunoprecipitation assays 
strongly suggest that both proteins are 
associated in vivo. Moreover, PrPc 
interaction with either STI1 or peptid 
representing the ST1 binding domain 
could induce neuroprotective signals 
through a cAMP/PKA signalling 
pathway that rescue cells from 
apoptosis(Zanata SM et al., 2002). 
 
The intrinsic pathway 
Bcl-2/Bax 
iginally identified 
mosomal breakpoint of the 
he speculation that PrPc may be a 
dismutase (SOD) was 
The bcl-2 gene was or
at the chro
translocation of chromosome 18 to 14 in 
follicular non-Hodgkin lymphoma 
(NHL)(Tsujimoto Y et al., 1984).The 
Bcl-2 family, key regulators of apoptosis, 
includes proapoptotic members such as 
Bax, Bak, Bad, Bcl-Xs, Bid, Bik, Bim, 
and Hrk, and antiapoptotic members such 
as Bcl-2, Bcl-XL, Bcl-W, Bfl-1, and 
Mcl-1(Reed JC., 1994). Experiments in 
our laboratory showed by western blot 
that cells transfected with PrPc would 
down-regulate Bax and up-regulate Bcl-2, 
suggesting PrPc played an important role 
in anti-apoptosis pathways (Du J et al., 
2005; Liang J et al., 2006).Analysis of 
interaction sites in homo- and 
heteromeric complexes containing Bcl-2 
family members and the cellular prion 
protein showed that PrPc binds to the 
C-terminus of Bcl-2 but not 
Bax(Kurschner C and Morgan JI, 1996). 
Bax binding required almost the entire 
Bcl-2 molecule, while PrP associated 
with the carboxy terminus of Bcl-2 
(amino acids 200-236). Antiapoptotic 
Bcl-2 members act as repressors of 
apoptosis by blocking the release of 
cytochrome-c, whereas proapoptotic 
members act as promoters. These effects 
are more dependent on the balance 
between Bcl-2 and Bax than on Bcl-2 
quantity alone(Reed JC, 1998). PrPc may 
disrupt chains of Bcl-2 molecules at the 
homomeric association site in the 
transmembrane region to reduce the 
release of cytochrome-c.  
 
SOD/ROS 
T
superoxide 
perceived as particularly attractive in 
view of its multiple copper binding sites 
in N-terminal octapeptide repeat region, 
and it was suggested that 
amino-proximally truncated PrPc may 
depress endogenous dismutase 
activity(Akikazu Sakudoa et al., 2005). 
Compared apoptosis of Prnp(-/-) cells 
with that of Prnp(-/-) cells expressing the 
wild-type PrPc or PrPc lacking 
N-terminal octapeptide repeat region 
under serum-free conditions showed 
re-introduction of PrPc rescued cells 
from apoptosis, upregulated superoxide 
dismutase (SOD) activity, enhanced 
superoxide anion elimination, and 
inhibited caspase-3/9 activation. On the 
other hand, N-terminally truncated PrPc 
enhanced apoptosis accompanied by 
potentiation of superoxide production 
and caspase-3/9 activation due to 
inhibition of SOD(Sakudo A et al., 2003). 
Reactive oxygen species (ROS), 
prevented by an antioxidant system: low 
molecular mass antioxidants, enzymes 
regenerating the reduced forms of 
antioxidants and ROS-interacting 
enzymes such as SOD (Blokhina O et al., 
2003), is produced in mitochondria and 
could control the expression of Bcl-2 
family proteins by regulating their 
phosphorylation and ubiquitination (Li D 
et al., 2004). In vitro transfectant of 
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AGS/PrPc was observed to stimulate less 
ROS as compared to that of 
AGS/pcDNA3.1B by us (Liang J., 2006). 
These results suggest that PrPc protects 
cells from apoptosis via superoxide- and 
mitochondria-dependent pathways by 
upregulating SOD activity. 
 
Calcium channel 
Ca2+ signalling is involved in virtually 
es: among the others, 
al death signals, 
roapoptotic proteins undergo post 
he final pathway that leads to execution 
ation of a 
all cellular process
it controls cell survival, proliferation and 
death regulating a plethora of 
intracellular enzymes located in the 
cytoplasm, nucleus and organelles 
(Munaron L et al., 2004). Synthetic 
fragments of PrP106-126 has been shown 
to be toxic to neurons in culture and cell 
death occurs by apoptosis was observed 
to involve Ca2+ uptake through 
voltage-sensitive Ca2+ channels(Brown 
DR et al., 1997). Microfluorimetric 
analysis was applied to monitor 
intracellular calcium concentration of 
single cell and showed that PrP 106-126 
caused a complete blockade of the 
increase in the cytosolic calcium levels 
induced by K+ depolarization. 
Electrophysiological studies 
demonstrated the L-type 
voltage-sensitive calcium channel 
blocker nicardipine could also induce 
apoptosis(Florio T et al., 1998; Thellung 
S et al., 2000). These data demonstrate 
that PrP106-126 may alter the activity of 
L-type voltage-sensitive calcium 
channels and control the release of 
cytochrome-c from the mitochondia to 
regulate cell apoptosis. 
 
Following above sever
p
translational modifications that include 
dephosphorylation and cleavage resulting 
in their activation and translocation to the 
mitochondria leading to apoptosis 
(Scorrano L and Korsmeyer S, 2003). In 
response to apoptotic stimuli, the outer 
mitochondrial membrane becomes 
permeable, leading to the release of 
cytochrome-c and second 
mitochondria-derived activator of 
caspase. Cytochrome-c, once released in 
the cytosol, interacts with Apaf-1, 
leading to the activation of caspase-9 
proenzymes. Active caspase-9 then 
activates caspase-3, which subsequently 
activates the rest of the caspase cascade 
and leads to apoptosis. Activated 
caspases lead to the cleavage of nuclear 
lamin and breakdown of the nucleus 
through caspase-3(Reed JC, 1997). 
 
The final pathway: Caspases 
T
of the death signal is the activ
series of proteases termed caspases. 
Although not all caspases are involved in 
apoptosis, the caspases that have been 
well described are caspases-3, -6, -7, -8, 
and -9(Thornberry NA and Lazebnik Y, 
1998; Mancini M et al., 1998). The 
intrinsic and extrinsic apoptotic pathways 
converge to caspase-3, which cleaves the 
inhibitor of the caspase-activated 
deoxyribonuclease, and the 
caspase-activated deoxyribonuclease 
becomes active leading to nuclear 
apoptosis. The upstream caspases that 
converge to caspase-3 are caspases-9 and 
-8 in the intrinsic and extrinsic pathways, 
respectively(Hachiya NS et al., 2005; 
Hachiya NS et al., 2005; Hetz C et al., 
2005). The downstream caspases induce 
cleavage of protein kinases, cytoskeletal 
proteins, DNA repair proteins, inhibitory 
subunits of endonucleaes (CIDE family), 
and finally, destruction of 
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“housekeeping” cellular functions (Fig 2). 
Caspases also affect cytoskeletal 
structure, cell cycle regulation, and 
signaling pathways, ultimately leading to 
the morphologic manifestations of 
apoptosis, such as DNA condensation 
and fragmentation, and membrane 
blebbing(Irene M et al., 2005). 
 
p53
p38/MAPK
 
Figure 2: Pathways related to apoptosis in PrPc. PrPc may participate in apoptosis 
egulation of the apoptotic proteins 
tion has been implicated 
from wild-type rodents, but not from 
ies to PrPc 
through extrinsic pathway by binding to certain chaperon molecules like ST1 or suffer 
from stress like inflammatory factors like TNF-α. It can also by modulating Bcl-2/Bax, 
endogenous dismutase activity and calcium channel, control the activation and 
translocation of the mitochondria which leads to apoptosis involving certain effective 
molecules of caspase family. Meanwhile above biological events would be controlled 
by cAMP/APK, p38/MAPK, JNK, p53, NF-κB pathways. 
 
R
cAMP/PKA 
PKA activa
previously in the regulation of apoptosis 
in some studies. In the retinal explanted 
from neonatal rats or mice kept in vitro 
for 24 h and anisomycin (ANI) induced 
apoptosis model, the peptide activated 
both cAMP/protein kinase A (PKA) and 
Erk pathways, and partially prevented 
cell death induced by ANI in explants 
PrPc-null mice. Neuroprotection was 
abolished by treatment with 
phosphatidylinositol-specific 
phospholipase C, with human peptide 
106-126, with certain antibod
or with a PKA inhibitor, but not with a 
MEK/Erk inhibitor. In contrast, 
antibodies to PrPc that increased cAMP 
also induced neuroprotection. Thus, 
engagement of PrPc transduces 
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neuroprotective signals through a 
cAMP/PKA-dependent pathway(Chiarini 
LB et al., 2002). 
 
p38/MAPK 
p38 MAPKs are members of the MAPK 
re activated by a variety of family that a
environmental stresses and inflammatory 
cytokines(Lewis TS et al., 1998). The 
p38 MAPkinase blockers, SB203580 and 
PD169316 were observed to prevent the 
apoptotic cell death evoked by 
PrP106-126 and western blot analysis 
revealed that the exposure of the cells to 
the peptide induced p38 phosphorylation 
in SH-SY5Y cell(Thellung S et al., 2002). 
Controversially, a recent report by 
Carimalo et al. (Carimalo J et al., 2005) 
observed MAPK p38 inhibitor SB203580 
couldn’t reduce PrP106-126 exposure to 
its aggregated form and couldn’t reverse 
its induction to a massive neuronal death. 
The reason may lie in the different cell 
models they used. 
  
JNK 
Carimalo et al. (Carimalo et al., 2005) 
immunocytochemistry showed a 
53 functions as a transcription factor 
ating downstream genes important 
F-κB is a nuclear transcription factor 
ulates expression of a large 
used 
peak of phosphorylated c-Jun-N-terminal 
kinase (JNK) translocation into the 
nucleus after 8 h in the PrP106-126 
induced neuronal cell death model, along 
with the activation of the nuclear c-Jun 
transcription factor. Both 
pharmacological inhibition of JNK by 
SP600125 and overexpression of a 
dominant negative form of c-Jun 
significantly reduced neuronal death in 
neuronal apoptosis induced by 
PrP106-126. Apoptosis was also studied 
after exposure of tg338 cortical neurons 
in primary culture to sheep scrapie agent 
by them. In this model, prion-induced 
neuronal apoptosis was found to increase 
gradually along with time, with 40% cell 
death after 2 weeks exposure. 
Immunocytochemical analysis showed 
early c-Jun activation after 7 days. They 
deduced that JNK-c-Jun pathway plays 
an important role in neuronal apoptosis 
induced by PrP106-126. 
 
p53 
p
regul
in cell cycle arrest, DNA repair, and 
apoptosis. After DNA damage, p53 holds 
the cell at a checkpoint until the damage 
is repaired. If the damage is irreversible, 
apoptosis is triggered Benchimol 
(Benchimol S, 2001). Results from 
several laboratories indicate that 
apoptosis via the p53 pathway is 
involved in prion disease pathogenesis. 
PrPc expression was found to enhance 
staurosporine-stimulated neuronal 
toxicity and DNA fragmentation, caspase 
3-like activity and immunoreactivity, and 
p53 immunoreactivity and transcriptional 
activities(Paitel E, 2003). PrPc could 
control p53 at a post-transcriptional level 
and is reversed by Mdm2 transfection 
and p38 MAPK inhibitor. So it’s 
proposed that endogenous cellular prion 
protein sensitizes cells to apoptotic 
stimuli through a p53-dependent caspase 
3-mediated activation controlled by 
Mdm2 and p38 MAPK. Combined 
pharmacological, mutational and cell 
biology approaches also indicate that 
p53-dependent caspase 3 activation 
triggered by cellular prion is dependent 
on its endocytosis(Sunyach C and 
Checler F, 2005). 
 
NF-κB 
N
that reg
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number of genes involved in the 
regulation of apoptosis, viral replication, 
tumorigenesis, inflammation, and many 
autoimmune diseases(Maldonado V et al., 
1997) In its inactive form, NF-κB is 
sequestered in the cytoplasm, bound 
inhibitor proteins of the I-κB family. The 
various stimuli that activate NF-κB cause 
phosphorylation of I-κB, which is 
followed by its degradation. This results 
in exposure of the nuclear localization 
signals on NF-κB subunits and the 
subsequent translocation of the molecule 
to the nucleus. In the nucleus, NF-κB 
binds with the consensus sequence of 
various genes and thus activates their 
transcription. NF-κB has been shown to 
have both anti- and pro-apoptotic 
functions that may be determined by the 
nature of the death stimulus rather than 
by the origin of the tissue (Maldonado V 
et al., 2000). Under physiologic 
conditions, the activation of NF-κB 
induces resistance to apoptotic stimuli 
through the activation of many complex 
proteins including PrPc combining 
proteins. However, in response to certain 
stimuli, NF-κB activation may lead to 
induction of apoptosis. Activation by 
prion peptide PrP106-126 could induce a 
NF-κB-driven pro-inflammatory 
response in human monocyte-derived 
dendritic cells (Bacot SM et al., 2003). 
While other research revealed prion 
accumulation in astrocytes might activate 
NF-κB through the increase of ROS 
generation, and thus alterations in 
NF-κB-directed gene expression may 
contribute to both the neurodegeneration 
and proinflammatory responses (Kim JI 
et al.,1999). 
 
CONCL
Akikazu
USION 
Apoptosis, biological 
henomena, plays a vital role in the 
This study was 
upported in part by grant from the 
CES 
 Saku Lee, Takuya 
ishimuraa, Shuming Li, Shoutaro Tsuji, 
ier-Jessen MR,  
the important 
p
biological function of PrPc. PrPc may 
participate in apoptosis through extrinsic 
pathway by binding to certain chaperon 
molecules or through induced by certain 
stresses like inflammatory factors. It can 
also by modulating Bcl-2/Bax, 
endogenous dismutase activity and 
calcium channel, control the activation 
and translocation of the mitochondria 
which leads to apoptosis involving 
certain effective molecules of caspase 
family. Meanwhile above biological 
events would be controlled by 
cAMP/APK, p38/MAPK, JNK, p53, 
NF-κB pathways et al. Further 
understanding of the apoptosis in PrPc 
have important implications for 
designing therapy of prion diseases, as 
well as for understanding pathogenic 
mechanisms operative in other 
neurodegenerative disorders and the role 
of prion in biology.  
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